4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-20-041565
Chief Medical Officer gave up 1,360 shares (to pay taxes)
- Chief Medical Officer acquired 6,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gordon David N. Chief Medical Officer | 2020-07-02 | Option exercise | +6,000 | 88,895 | D | ||
| Gordon David N. Chief Medical Officer | 2020-07-02 | Shares withheld for taxes | −1,360 | $1.50 | $2,040 | 87,535 | D |
| Derivatives | |||||||
| Gordon David N. Chief Medical Officer | 2020-07-02 | Option exercise · Restricted stock units | −6,000 | 12,000 | D | ||
Loading xslF345X03/doc4.xml…